Skip to main content
Elsevier

Glioblastoma, Part II: Molecular Targets and Clinical Trials, An Issue of Neurosurgery Clinics of North America

  • 1st Edition, Volume 32-2 - April 8, 2021
  • Latest edition
  • Editor: Linda Liau
  • Language: English

This issue of Neurosurgery Clinics, guest edited by Dr. Linda M. Liau, is dedicated to Glioblastoma: Molecular and Clinical Trials. This issue is one of four selected each year by… Read more

Purchase options

Info / Buy

Description

This issue of Neurosurgery Clinics, guest edited by Dr. Linda M. Liau, is dedicated to Glioblastoma: Molecular and Clinical Trials. This issue is one of four selected each year by the series consulting editors, Drs. Russell R. Lonser and Daniel K. Resnick. Topics will include—but are not limited to—Pathology & Molecular Markers, Cellular States & Genetic Diversity in Glioblastoma, Mismatch Repair in Glioblastoma Resistance, Genetic Susceptibility in Brain Cancer, Pediatric Gliomas: Molecular Landscape & Emerging Targets, Molecularly Targeted Clinical Trials, Novel Radiation Sensitizers, Immunotherapy Checkpoint Inhibitors, Brain Tumor Vaccines, CAR T Cells, Oncolytic Virotherapy, Targeting Cancer Stem Cells, Therapeutic Delivery to CNS, Theranostics: Dual Modality PET Tracers, and Neuroimaging & Novel Response Assessments.

Product details

  • Edition: 1
  • Latest edition
  • Volume: 32-2
  • Published: April 8, 2021
  • Language: English

About the editor

LL

Linda Liau

Dr. Linda Liau is Chair, Professor, and Director of the Brain Tumor Program for the Department of Neurosurgery at UCLA. She has an NIH-funded laboratory with a busy surgical practice involving intraoperative functional brain mapping for resection of brain tumors. She is the former Editor-in-Chief of the Journal of Neuro-Oncology and is the director of the UCLA Brain Cancer SPORE (Specialized Program of Research Excellence). She is an elected member of the National Academy of Medicine and has led phase 3 clinical trials for dendritic cell vaccination strategies in patients with glioblastoma.

Affiliations and expertise
Chair, Professor, and Director of the Brain Tumor Program, Department of Neurosurgery, UCLA